Comerica Bank lifted its position in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 13.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 73,166 shares of the scientific and technical instruments company's stock after buying an additional 8,566 shares during the period. Comerica Bank owned approximately 0.79% of Transcat worth $5,447,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of TRNS. Quantbot Technologies LP acquired a new stake in Transcat in the 1st quarter worth approximately $76,000. Aquatic Capital Management LLC boosted its stake in Transcat by 1,052.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after purchasing an additional 1,052 shares in the last quarter. GAMMA Investing LLC boosted its stake in Transcat by 10,137.5% in the 1st quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company's stock worth $122,000 after purchasing an additional 1,622 shares in the last quarter. US Bancorp DE boosted its stake in Transcat by 14.6% in the 1st quarter. US Bancorp DE now owns 1,770 shares of the scientific and technical instruments company's stock worth $132,000 after purchasing an additional 226 shares in the last quarter. Finally, ProShare Advisors LLC boosted its stake in Transcat by 49.1% in the 4th quarter. ProShare Advisors LLC now owns 2,542 shares of the scientific and technical instruments company's stock worth $269,000 after purchasing an additional 837 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.
Transcat Stock Performance
NASDAQ TRNS traded down $2.12 on Wednesday, hitting $81.80. 52,700 shares of the company's stock traded hands, compared to its average volume of 106,226. The company has a current ratio of 2.92, a quick ratio of 2.36 and a debt-to-equity ratio of 0.11. The firm's 50-day moving average price is $83.33 and its two-hundred day moving average price is $80.88. Transcat, Inc. has a 1-year low of $67.56 and a 1-year high of $133.72. The firm has a market capitalization of $762.29 million, a PE ratio of 57.20 and a beta of 0.72.
Transcat (NASDAQ:TRNS - Get Free Report) last posted its earnings results on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.19. Transcat had a net margin of 4.64% and a return on equity of 6.66%. The firm had revenue of $76.42 million during the quarter, compared to analysts' expectations of $72.28 million. As a group, analysts expect that Transcat, Inc. will post 2.3 EPS for the current year.
Wall Street Analyst Weigh In
A number of analysts recently commented on TRNS shares. Lake Street Capital started coverage on shares of Transcat in a research note on Thursday, July 10th. They issued a "buy" rating and a $105.00 target price for the company. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday, May 28th. Finally, HC Wainwright reiterated a "buy" rating and issued a $116.00 target price on shares of Transcat in a research note on Friday, August 22nd. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $112.20.
Read Our Latest Report on Transcat
About Transcat
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also

Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.